P&G to co-promote Somaxon's Silenor; deal amended; then ended
- OTC, Consumer
- Includes Contract
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.